Fresh Recalls

FDAClass II · Drug · Recall D-0016-2027 · Recalled October 14, 2026

IMAAVY (nipocalimab-aahu) Injection recall — J&J INNOVATIVE MEDICINE

Agency report date: October 14, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
IMAAVY (nipocalimab-aahu) Injection
Company / brand
J&J INNOVATIVE MEDICINE
Lot / serial / date codes
Lot JNYJ1208; Exp. 10/30/2027
Distribution
OH
Agency product description and boundaries

IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Presence of particulate matter.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: IMAAVY (nipocalimab-aahu) Injection recall status

3. Open the official notice or contact

Official recall ID
D-0016-2027
Brand
All J&J INNOVATIVE MEDICINE recalls
Classification
Class II
Units affected
49 vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Malvern, PA, United States
Firm address
200 Great Valley Pkwy, N/A, 19355-1307

Identifying details (verbatim from the notice)

Product codes / lots
Lot JNYJ1208; Exp. 10/30/2027
Distribution
OH
Firm notified the public via
Letter
FDA event ID
99972
Recall initiated
September 23, 2026
FDA classified
October 8, 2026
FDA report date
October 14, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 6:00 PM UTC. Record retrieved October 22, 2026 at 6:00 PM UTC.

Report a data error on this page